The role of Health Economics in informing policy globally

12:30-1:30pm Monday 6 December 2021
Zoom registration

Natalie Carvalho will introduce concepts of health economics including how health economic evidence can be used in informing policy at a national level, with a focus on infectious diseases. Showcasing examples from projects conducted alongside the Murdoch Children’s Research Institute, in collaboration with partners in the Asia Pacific region, Natalie will discuss the key approaches, benefits, and challenges associated with conducting health economic evaluations to support evidence-based public health decisions.

Emma Watts will discuss a cost effectiveness analysis of Rotavirus Vaccine introduction in Indonesia.


Natalie Carvalho is a Senior Research Fellow in the Health Economics Unit, Centre for Health Policy at Melbourne School of Population and Global Health. Her research focuses primarily on developing evidence for priority-setting of health interventions targeting infectious diseases in low- and middle-income countries using economic evaluation. She has been involved in large-scale cost-effectiveness analyses – comparing 100s of possible interventions – that have been used to guide policy-making in settings such as Mexico and the Pacific. She is Chief Investigator on two NHMRC Centres of Research Excellence awards focused on infectious diseases in Australia and the Asia Pacific Region. Natalie holds an honorary appointment with Murdoch Children’s Research Institute and teaches several short courses in economic evaluation.

Emma Watts is an experienced research manager at MCRI with a strong interest in economic evaluation of child health interventions. She has been involved in cost effectiveness studies of HPV, Rotavirus, Pneumococcal and Meningococcal C vaccines. Emma was the Project Manager for the phase IIb clinical trial of the RV3 Rotavirus Vaccine in Indonesia and has recently modelled the cost effectiveness of Rotavirus Vaccine introduction in Indonesia, in a collaboration between Enteric Diseases Group of MCRI and Universitas Gadjah Mada, Indonesia.

Comments are closed.